In the context of this study, we observed that CELF1 is expressed and functional across diverse molecular subgroups of breast cancer; additionally, by modulating the expression of GLUT1, CELF1 stimulates aerobic glycolysis in breast cancer cells. The gene discussed is SLC2A1; the disease is breast carcinoma.